Your browser doesn't support javascript.
loading
Modafinil for the treatment of cocaine dependence.
Anderson, Ann L; Reid, Malcolm S; Li, Shou-Hua; Holmes, Tyson; Shemanski, Lynn; Slee, April; Smith, Edwina V; Kahn, Roberta; Chiang, Nora; Vocci, Frank; Ciraulo, Domenic; Dackis, Charles; Roache, John D; Salloum, Ihsan M; Somoza, Eugene; Urschel, Harold C; Elkashef, Ahmed M.
Afiliación
  • Anderson AL; Division of Pharmacotherapies and Medical Consequences of Drug Abuse, National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD 20892-9551, USA. aa135m@nih.gov
Drug Alcohol Depend ; 104(1-2): 133-9, 2009 Sep 01.
Article en En | MEDLINE | ID: mdl-19560290
AIM: Modafinil was tested for efficacy in facilitating abstinence in cocaine-dependent patients, compared to placebo. METHODS: This was a double-blind placebo-controlled study, with 12 weeks of treatment and a 4-week follow-up. Six outpatient substance abuse treatment clinics participated in the study. There were 210 treatment-seekers randomized, having a diagnosis of cocaine dependence; 72 participants were randomized to placebo, 69 to modafinil 200mg, and 69 to modafinil 400mg, taken once daily on awakening. Participants came to the clinic three times per week for assessments and urine drug screens, and had one hour of individual psychotherapy weekly. The primary outcome measure was the weekly percentage of cocaine non-use days. RESULTS: The GEE regression analysis showed that for the total sample, there was no significant difference between either modafinil group and placebo in the change in average weekly percent of cocaine non-use days over the 12-week treatment period (p>0.79). However, two secondary outcomes showed significant effects by modafinil 200mg: the maximum number of consecutive non-use days for cocaine (p=0.02), and a reduction in craving (p=0.04). Also, a post hoc analysis showed a significant effect of modafinil that increased the weekly percentage of non-use days in the subgroup of those cocaine patients who did not have a history of alcohol dependence (p<0.02). CONCLUSIONS: These data suggest that modafinil, in combination with individual behavioral therapy, was effective for increasing cocaine non-use days in participants without co-morbid alcohol dependence, and in reducing cocaine craving.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Compuestos de Bencidrilo / Trastornos Relacionados con Cocaína / Estimulantes del Sistema Nervioso Central Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: Drug Alcohol Depend Año: 2009 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Irlanda

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Compuestos de Bencidrilo / Trastornos Relacionados con Cocaína / Estimulantes del Sistema Nervioso Central Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: Drug Alcohol Depend Año: 2009 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Irlanda